• 1
    Heidenreich A, Bellmunt J, Bolla M et al. EAU Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 6171
  • 2
    Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 97580
  • 3
    Stokes SH. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys 2000; 47: 12936
  • 4
    Malcolm JB, Fabrizio MD, Barone BB et al. Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol 2010; 183: 18228
  • 5
    Sanda MG, Dunn RL, Michalski J et al. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors 22. N Engl J Med 2008; 358: 125061
  • 6
    Mallick S, Azzouzi R, Cormier L, Peiffert D, Mangin PH. Urinary morbidity after 125I brachytherapy of the prostate. BJU Int 2003; 92: 5558
  • 7
    Downs TM, Sadetsky N, Pasta DJ et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-data from CaPSURE. J Urol 2003; 170: 18227
  • 8
    Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2001; 51: 61423
  • 9
    Wagner TT, Nag S, Young D, Bahnson RR. Early voiding dysfunction associated with prostate brachytherapy. Urol Oncol 2000; 6: 203
  • 10
    Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 36576
  • 11
    Donovan JL, Abrams P, Peters TJ et al. The ICS-’BPH’ Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1995; 77: 55462
  • 12
    O’Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol 1992; 47: M11621
  • 13
    Jakse G, Manegold E, Reineke T et al. Die erweiterte, radikale perineale Prostatektomie. Urologe 2000; 39: 45562
  • 14
    Weldon VE. Radical perineal prostatectomy. In Sakti D, Crawford ED eds, Cancer of the Prostate, New York, Basel, Hong Kong: Marcel Dekker, Inc., 1993: 22565
  • 15
    Hautmann RE, Huland H. Urologie, 2nd edn. Berlin, Heidelberg, New York: Springer-Verlag, 2001
  • 16
    Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000; 57: 31521
  • 17
    Herschorn S, Bruschini H, Comiter C, Grise P, Hanus T, Kirschner-Hermanns R. Surgical treatment of urinary incontinence in men. In Abrams P, Cardozo L, Khoury S, Wein A eds, 4th International Consultation on Incontinence, 4th edn. Book chapter 13. Plymouth: Health Publication Ltd, 2009: 112190
  • 18
    Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 43548
  • 19
    Ebara S, Katayama N, Tanimoto R et al. Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer. Acta Med Okayama 2008; 62: 913
  • 20
    Stone NN, Stock RG. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy. Brachytherapy 2003; 2: 329
  • 21
    Penson DF, Feng Z, Kuniyuki A et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21: 114754
  • 22
    Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG. Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 2000; 164 (3 Pt 1): 7448
  • 23
    DuBeau CE, Yalla SV, Resnick NM. Implications of the most bothersome prostatism symptom for clinical care and outcomes research. J Am Geriatr Soc 1995; 43: 98592
  • 24
    Aslan E, Beji NK, Erkan HA, Yalcin O, Gungor F. Urinary incontinence (UI) and quality of life (QoL) of the elderly residing in residential homes in Turkey. Arch Gerontol Geriatr 2009; 49: 30410
  • 25
    Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health related quality of stress, urge and mixed urinary incontinence. BJU Int 2003; 92: 7315
  • 26
    Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004; 172 (6 Pt 1): 222731
  • 27
    Sacco E, Prayer-Galetti T, Pinto F et al. Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up. BJU Int 2006; 97: 123441
  • 28
    Geary ES, Dendinger TE, Freiha FS, Stamey TA. Incontinence and vesical neck strictures following radical retropubic prostatectomy. Urology 1995; 45: 10006
  • 29
    Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical prostatectomy on urinary continence. J Urol 1991; 145: 5124
  • 30
    Kirschner-Hermanns R, Brehmer RB, Borchers H. Do patients with urodynamically proven infravesical obstruction and detrusor overactivity have a higher risk for long term bothersome symptoms after brachytherapy in comparison to patients treated with radical prostatecomy for localized prostate cancer? Curr Urol 2009; 2: 13541
  • 31
    Du Beau C, Levy B, Mangione CM, Resnick NM. The impact of urge urinary incontinence on quality of life: importance of patients’ perspective and explanatory style. J Am Geriatr Soc 1998; 46: 68392
  • 32
    Knoll L, Felten MK, Ackermann D, Kraus T. Non-response bias in a surveillance program for asbestos-related lung cancer. J Occup Health 2011; 53: 1622
  • 33
    Hazell ML, Morris JA, Lineham MF, Frank PI, Frank TL. Factors influencing the response to postal questionnaire surveys about respiratory symptoms. Prim Care Respir J 2009; 18: 16570